QR-koda

A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications

Bo Ding,1 Mark Small,2 Ulf Holmgren3 1Medical Evidence and Observational Research, AstraZeneca Gothenburg, Mölndal, Sweden; 2Real World Research (Respiratory), Adelphi Real World, Bollington, UK; 3Global Payer Evidence and Pricing, AstraZeneca Gothenburg, Mölndal, Sweden Background: As p...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Ding B, Small M, Holmgren U
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Dove Medical Press 2017-05-01
Ráidu:International Journal of COPD
Fáttát:
bronchodilators
COPD
treatment
GOLD group
symptom
routine care
Liŋkkat:https://www.dovepress.com/a-cross-sectional-survey-of-current-treatment-and-symptom-burden-of-pa-peer-reviewed-article-COPD
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid